See more : MGI – Media and Games Invest SE (MDGIF) Income Statement Analysis – Financial Results
Complete financial analysis of TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TELCON RF PHARMACEUTICAL. Inc., a leading company in the Communication Equipment industry within the Technology sector.
- Verizon Communications Inc. (BAC.DE) Income Statement Analysis – Financial Results
- The Allstate Corporation (0HCZ.L) Income Statement Analysis – Financial Results
- Thaicom Public Company Limited (THCOM.BK) Income Statement Analysis – Financial Results
- Universal Cables Limited (UNIVCABLES.BO) Income Statement Analysis – Financial Results
- Great-West Lifeco Inc. (0AH3.L) Income Statement Analysis – Financial Results
TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)
About TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 36.31B | 27.83B | 37.84B | 33.14B | 52.48B | 57.71B | 41.15B | 29.84B | 28.54B | 58.76B | 46.64B | 35.22B |
Cost of Revenue | 26.80B | 25.22B | 31.79B | 28.83B | 40.51B | 51.46B | 37.71B | 27.10B | 24.07B | 46.40B | 34.26B | 26.81B |
Gross Profit | 9.51B | 2.61B | 6.06B | 4.31B | 11.97B | 6.25B | 3.44B | 2.74B | 4.47B | 12.36B | 12.37B | 8.42B |
Gross Profit Ratio | 26.19% | 9.39% | 16.00% | 13.01% | 22.81% | 10.83% | 8.37% | 9.19% | 15.68% | 21.03% | 26.53% | 23.89% |
Research & Development | 733.17M | 1.21B | 1.64B | 1.82B | 1.63B | 3.80B | 5.33B | 1.79B | 1.75B | 1.55B | 1.52B | 756.15M |
General & Administrative | 329.51M | 294.43M | 522.76M | 553.65M | 40.74M | 102.90M | 137.90M | 110.39M | 59.62M | 61.16M | 46.56M | 44.68M |
Selling & Marketing | 937.97M | 904.24M | 2.70B | 2.67B | 1.32B | 2.47B | 2.75B | 2.28B | 632.44M | 674.75M | 643.28M | 218.85M |
SG&A | 4.74B | 5.40B | 8.82B | 4.53B | 7.22B | 11.60B | 10.64B | 8.98B | 2.98B | 2.63B | 959.25M | 2.04B |
Other Expenses | 0.00 | -68.03M | -168.30M | -53.62M | -46.05M | -240.55M | -369.43M | -521.91M | -32.27M | 0.00 | 0.00 | 0.00 |
Operating Expenses | 5.47B | 6.68B | 10.62B | 6.40B | 8.89B | 15.64B | 16.34B | 11.30B | 4.76B | 4.14B | 2.28B | 2.56B |
Cost & Expenses | 32.27B | 31.89B | 42.40B | 35.23B | 49.40B | 67.10B | 54.05B | 38.39B | 28.83B | 50.54B | 36.54B | 29.37B |
Interest Income | 188.89M | 54.73M | 45.48M | 57.21M | 55.11M | 4.74B | 2.59B | 502.91M | 684.68M | 277.73M | 6.54M | 123.61M |
Interest Expense | 603.58M | 1.06B | 7.70B | 2.85B | 1.83B | 5.12B | 3.35B | 1.07B | 570.00 | 1.24K | 1.28K | 0.00 |
Depreciation & Amortization | 4.24B | 4.28B | 4.20B | 4.40B | 4.43B | 4.12B | 2.17B | 1.33B | 541.76M | 428.43M | 224.74M | 189.36M |
EBITDA | 16.82B | -36.77B | -363.07M | -30.73B | -33.42B | -5.93B | -14.89B | -3.65B | 255.70M | 8.50B | 10.08B | 5.79B |
EBITDA Ratio | 46.32% | 0.79% | -0.96% | 6.96% | 14.31% | -9.14% | -26.07% | -24.21% | 0.90% | 14.46% | 21.62% | 16.43% |
Operating Income | 4.04B | -4.06B | -4.56B | -2.09B | 3.08B | -9.39B | -12.90B | -8.55B | -286.06M | 8.07B | 9.86B | 5.60B |
Operating Income Ratio | 11.12% | -14.60% | -12.06% | -6.31% | 5.86% | -16.27% | -31.34% | -28.67% | -1.00% | 13.73% | 21.14% | 15.89% |
Total Other Income/Expenses | 7.93B | -38.05B | -20.13B | -39.56B | -58.09B | -7.30B | -7.70B | 1.52B | 917.32M | 317.70M | 246.45M | 133.17M |
Income Before Tax | 11.97B | -37.30B | -9.62B | -37.97B | -39.68B | -15.17B | -20.41B | -6.05B | 710.20M | 8.49B | 10.11B | 5.73B |
Income Before Tax Ratio | 32.97% | -134.03% | -25.41% | -114.58% | -75.61% | -26.29% | -49.60% | -20.29% | 2.49% | 14.45% | 21.67% | 16.27% |
Income Tax Expense | -1.98B | -32.81M | -108.80M | 18.95M | 332.20K | 1.42M | 55.53M | -1.50B | 283.05M | 1.75B | 2.22B | 1.25B |
Net Income | 13.91B | -42.08B | -23.10B | -40.89B | -52.65B | -13.75B | -16.44B | -3.44B | 348.21M | 6.74B | 7.89B | 4.48B |
Net Income Ratio | 38.30% | -151.22% | -61.04% | -123.39% | -100.33% | -23.83% | -39.95% | -11.52% | 1.22% | 11.47% | 16.92% | 12.72% |
EPS | 124.00 | -396.72 | -262.93 | -477.80 | -635.43 | -178.51 | -252.72 | -64.31 | 6.93 | 162.90 | 234.30 | 179.10 |
EPS Diluted | 92.99 | -396.72 | -262.93 | -477.80 | -635.43 | -178.51 | -252.72 | -64.31 | 6.93 | 162.90 | 234.30 | 179.10 |
Weighted Avg Shares Out | 112.15M | 106.08M | 87.85M | 85.59M | 82.86M | 77.05M | 65.06M | 53.46M | 50.22M | 41.38M | 33.67M | 25.01M |
Weighted Avg Shares Out (Dil) | 149.55M | 106.08M | 87.85M | 85.59M | 82.86M | 77.05M | 65.06M | 53.46M | 50.22M | 41.38M | 33.67M | 25.01M |
Source: https://incomestatements.info
Category: Stock Reports